SOLUBLE T-CELL ANTIGEN RECEPTORS - Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges - page 472

5. Card KF, Price-Schiavi SA, Liu B, Thomson E, Nieves E,
Belmont H, et al. (2004) A soluble single-chain T-cell receptor
IL-2 fusion protein retains MHC-restricted peptide specificity
and IL-2 bioactivity. Cancer Immunol.

20. Holler PD, Chlewicki LK, Kranz DM. (2003) TCRs with high
affinity for foreign pMHC show self-reactivity. Nat. Immunol.
4, 55-62.
21. Donermeyer DL, Weber KS, Kranz DM, Allen PM. (2006) The
study of high-affinity TCRs reveals duality in T cell
recognition of antigen: specificity and degeneracy. J. Immunol.
177, 6911-6919.
22. Wong RL, Liu B, Zhu X, You L, Kong L, Han KP, et al. (2011)
Interleukin-15:Interleukin-15 receptor {alpha} scaffold for
creation of multivalent targeted immune molecules. Protein
Eng. Des. Sel. 24, 373-383.
23. Wen J, Zhu X, Liu B, You L, Kong L, Lee HI, et al. (2008)
Targeting activity of a TCR/IL-2 fusion protein against estab-
lished tumors. Cancer Immunol. Immunother. 57, 1781-1794.
24. Schmidt MM, Wittrup KD. (2009) A modeling analysis of the
effects of molecular size and binding affinity on tumor target-
ing. Mol. Cancer Ther. 8, 2861-2871.
25. Kuball J, Hauptrock B, Malina V, Antunes E, Voss RH,
Wolfl M, et al. (2009) Increasing functional avidity of TCR-
redirected T cells by removing defined N-glycosylation sites in
the TCR constant domain. J. Exp. Med. 206, 463-475.
26. Li LP, Lampert JC, Chen X, Leitao C, Popovic J, Muller W,
et al. (2010) Transgenic mice with a diverse human T cell
antigen receptor repertoire. Nat. Med. 16, 1029-1034.
27. Sherman LA, Hesse SV, Irwin MJ, La Face D, Peterson P.
(1992) Selecting T cell receptors with high affinity for self-
MHC by decreasing the contribution of CD8. Science 258,
815-818.
28. Pien GC, Basner-Tschakarjan E, Hui DJ, Mentlik AN, Finn JD,
Hasbrouck NC, et al. (2009) Capsid antigen presentation flags
human hepatocytes for destruction after transduction by adeno-
associated viral vectors. J. Clin. Invest. 119, 1688-1695.
29. Henrickson SE, Mempel TR, Mazo IB, Liu B, Artyomov MN,
Zheng H, et al. (2008) T cell sensing of antigen dose governs
interactive behavior with dendritic cells and sets a threshold for
T cell activation. Nat. Immunol. 9, 282-291.
30. Vogelstein B, Lane D, Levine AJ. (2000) Surfing the p53
network. Nature 408, 307-310.
31. Vousden KH, Prives C. (2005) P53 and prognosis: new insights
and further complexity. Cell 120, 7-10.
32. Strano S, Dell'Orso S, Di Agostino S, Fontemaggi G, Sacchi A,
Blandino G. (2007) Mutant p53: an oncogenic transcription
factor. Oncogene 26, 2212-2219.
33. Kuball J, Schmitz FW, Voss RH, Ferreira EA, Engel R,
Guillaume P, et al. (2005) Cooperation of human tumor-
reactive CD4 þ and CD8 þ T cells after redirection of their
specificity by a high-affinity p53A2.1-specific TCR. Immunity
22, 117-129.
34. Cohen CJ, Zheng Z, Bray R, Zhao Y, Sherman LA, Rosenberg
SA, et al. (2005) Recognition of fresh human tumor by human
peripheral blood lymphocytes transduced with a bicistronic
retroviral vector encoding a murine anti-p53 TCR. J. Immunol.
175, 5799-5808.
35. Theobald M, Biggs J, Dittmer D, Levine AJ, Sherman LA.
(1995) Targeting p53 as a general tumor antigen. Proc. Natl.
Acad. Sci. USA 92, 11993-11997.

Immunother. 53,

345-357.
6. Novotny J, Ganju RK, Smiley ST, Hussey RE, Luther MA,
Recny MA, et al. (1991) A soluble, single-chain T-cell receptor
fragment endowed with antigen- combining properties. Proc.
Natl. Acad. Sci. USA 88, 8646-8650.
7. Hoo WF, Lacy MJ, Denzin LK, Voss EWJr, Hardman KD,
Kranz DM. (1992) Characterization of a single-chain T-cell
receptor expressed in Escherichia coli. Proc. Natl. Acad. Sci.
USA 89, 4759-4763.
8. Wulfing C, Pluckthun A. (1994) Correctly folded T-cell recep-
tor fragments in the periplasm of Escherichia coli. Influence of
folding catalysts. J. Mol. Biol. 242, 655-669.
9. Bentley GA, Boulot G, Karjalainen K, Mariuzza RA. (1995)
Crystal structure of the beta chain of a T cell antigen receptor.
Science 267, 1984-1987.
10. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson
MR, Peterson PA, et al. (1996) An alphabeta T cell receptor
structure at 2.5 A and its orientation in the TCR-MHC com-
plex. Science 274, 209-219.
11. Ward ES. (1992) Secretion of T cell receptor fragments from
recombinant Escherichia coli cells. J. Mol. Biol. 224, 885-890.
12. Plaksin D, Polakova K, McPhie P, Margulies DH. (1997) A
three-domain T cell receptor is biologically active and specifi-
cally stains cell surface MHC/peptide complexes. J. Immunol.
158, 2218-2227.
13. Chung S, Wucherpfennig KW, Friedman SM, Hafler DA,
Strominger JL. (1994) Functional three-domain single-chain
T-cell receptors. Proc. Natl. Acad. Sci. USA 91, 12654-12658.
14. Mosquera LA, Card KF, Price-Schiavi SA, Belmont HJ, Liu B,
Builes J, et al. (2005) In vitro and in vivo characterization of a
novel antibody-like single-chain TCR human IgG1 fusion
protein. J. Immunol. 174, 4381-4388.
15. Zhu X, Belmont HJ, Price-Schiavi S, Liu B, Lee HI, Fernandez
M, et al. (2006) Visualization of p53 (264-272)/HLA-A 0201
complexes naturally presented on tumor cell surface by a
multimeric soluble single-chain T cell receptor. J. Immunol.
176, 3223-3232.
16. Weidanz JA, Card KF, Edwards A, Perlstein E, Wong HC.
(1998) Display of functional alphabeta single-chain T-cell
receptor molecules on the surface of bacteriophage. J. Immu-
nol. Methods 221, 59-76.
17. Belmont HJ, Price-Schiavi S, Liu B, Card KF, Lee HI, Han KP,
et al. (2006) Potent antitumor activity of a tumor-specific
soluble TCR/IL-2 fusion protein. Clin. Immunol. 121,

29-39.
18. Li Y, Moysey R, Molloy PE, Vuidepot AL, Mahon T, Baston E,
et al. (2005) Directed evolution of human T-cell receptors with
picomolar affinities by phage display. Nat. Biotechnol. 23,
349-354.
19. Richman SA, Kranz DM. (2007) Display, engineering, and
applications of antigen-specific T cell receptors. Biom. Eng.
24, 361-373.